Brain Stimulation Devices Show Mixed Results for Heart Rate Variability
A systematic review of 13 RCTs finds tDCS, TMS, and tVNS produce no significant HRV improvements, calling for better-standardized protocols.
Summary
Researchers at Federal University of Paraíba conducted a systematic review and meta-analysis of 13 randomized controlled trials examining whether non-invasive brain stimulation techniques — transcranial direct current stimulation (tDCS), transcranial magnetic stimulation (TMS), and transcutaneous vagus nerve stimulation (tVNS) — can meaningfully improve heart rate variability (HRV), a key marker of autonomic nervous system health. Despite growing interest in these technologies for cardiovascular risk reduction, the analysis found no statistically significant effects on HRV frequency- or time-domain variables for either tDCS or tVNS. Evidence quality was rated moderate, and substantial protocol heterogeneity across studies limits firm conclusions. Larger, standardized trials are urgently needed.
Detailed Summary
Heart rate variability — the beat-to-beat variation in heart rhythm — is a well-established biomarker of autonomic nervous system (ANS) function and a predictor of cardiovascular health and longevity. Poor HRV is associated with higher risks of cardiac events, accelerated aging, and mortality. Non-invasive neuromodulation technologies have emerged as promising tools to recalibrate ANS balance without drugs or surgery, making this review particularly relevant to longevity-focused clinicians and researchers.
This systematic review and meta-analysis, registered in PROSPERO and following PRISMA guidelines, searched four major databases through October 2024. Thirteen randomized controlled trials were ultimately included: five evaluating tDCS, six evaluating tVNS, and two evaluating TMS — all compared against sham or control conditions in human participants, with HRV as a primary outcome.
Despite the theoretical rationale for each modality — tDCS modulates cortical excitability, TMS delivers focused magnetic pulses, and tVNS directly targets the vagus nerve to shift sympathovagal balance — the pooled meta-analysis found no statistically significant improvements in HRV frequency-domain or time-domain variables for tDCS or tVNS. TMS had too few trials for robust quantitative synthesis. Evidence quality was rated moderate for both tDCS and tVNS.
A critical takeaway is the extreme heterogeneity in stimulation parameters across studies — electrode placement, current intensity, session duration, and target populations varied widely. This makes it nearly impossible to identify optimal protocols or compare results meaningfully across trials.
For longevity-oriented practitioners, these findings urge caution before recommending neuromodulation devices for ANS optimization. While the biological mechanisms remain compelling, clinical evidence is not yet sufficient to support routine use. Larger, rigorously standardized RCTs are essential to determine whether these tools can reliably improve HRV and reduce cardiovascular risk.
Key Findings
- Meta-analysis of 13 RCTs found no statistically significant effect of tDCS on HRV frequency-domain variables.
- tVNS showed no significant effect on either frequency- or time-domain HRV measures across six trials.
- Evidence quality for tDCS and tVNS effects on HRV was rated moderate using established grading criteria.
- Significant heterogeneity in stimulation protocols across studies prevents identification of optimal parameters.
- Authors call for larger, standardized RCTs before neuromodulation can be recommended for ANS management.
Methodology
This was a PRISMA-compliant systematic review and meta-analysis registered in PROSPERO, searching Cochrane Library, Web of Science, PubMed, and Embase through October 2024. Only randomized controlled trials comparing tDCS, TMS, or tVNS against sham or control in humans with HRV outcomes were included. Thirteen RCTs met inclusion criteria; heterogeneity was assessed across all pooled analyses.
Study Limitations
Only 13 RCTs were available, many with small sample sizes, limiting statistical power and generalizability. Extreme heterogeneity in stimulation protocols across studies makes pooled effect estimates difficult to interpret and may mask true benefits of optimized protocols. The review was limited to abstract-level data for synthesis in this summary context, and TMS had insufficient trials for meta-analysis.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: